We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Neuromodulation Platform Receives CE Marking for Use with 3-Tesla MRI

By MedImaging International staff writers
Posted on 18 Feb 2015
Image: Senza SCS System Components (Photo courtesy of Nevro).
Image: Senza SCS System Components (Photo courtesy of Nevro).
An implantable Spinal Cord Simulation (SCS) platform intended for the treatment of chronic pain has received CE marking (Conformité Européenne) approval for expanded MR-conditional (Magnetic Resonance) labeling.

The CE marking will provide patients already receiving HF10 (High-Frequency, 10 kHz) SCS treatment with access to Magnetic Resonance Imaging (MRI) scans.

All versions of the 5-year-old SCS system, produced by Nevro (Menlo Park, CA, USA), can now be marketed in Europe and Australia, and anywhere the system is sold, for use with 1.5 Tesla and 3.0 Tesla MRI scans of the head and extremities. This is the first implantable SCS system to receive 3-Tesla compatibility.

The Senza SCS system delivers electrical pulses by means of small electrodes implanted near the spinal cord and connected to a battery-powered generator also implanted under the skin.

According to Michael DeMane, Chairman and Chief Executive Officer of Nevro, “We are pleased to offer even more imaging options for our patients. Nevro is a company that is continually looking to advance the SCS space, and this expanded MR-conditional labeling highlights our ongoing commitment to innovation.”

Related Links:

Nevro  


Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
40/80-Slice CT System
uCT 528
X-Ray Illuminator
X-Ray Viewbox Illuminators
Diagnostic Ultrasound System
DC-80A

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.